Louis Kayitalire

2021

In 2021, Louis Kayitalire earned a total compensation of $933.7K as Chief Medical Officer at F-star Therapeutics, a 9% decrease compared to previous year.

Compensation breakdown

Bonus$117,000
Option Awards$72,386
Salary$451,344
Stock Awards$248,530
Other$44,398
Total$933,657

Kayitalire received $451.3K in salary, accounting for 48% of the total pay in 2021.

Kayitalire also received $117K in bonus, $72.4K in option awards, $248.5K in stock awards and $44.4K in other compensation.

Rankings

In 2021, Louis Kayitalire's compensation ranked 9,003rd out of 12,415 executives tracked by ExecPay. In other words, Kayitalire earned more than 27.5% of executives.

ClassificationRankingPercentile
All
9,003
out of 12,415
28th
Division
Manufacturing
3,993
out of 5,501
27th
Major group
Chemicals And Allied Products
1,753
out of 2,371
26th
Industry group
Drugs
1,558
out of 2,092
26th
Industry
Pharmaceutical Preparations
1,160
out of 1,542
25th
Source: SEC filing on April 22, 2022.

Kayitalire's colleagues

We found three more compensation records of executives who worked with Louis Kayitalire at F-star Therapeutics in 2021.

2021

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2021

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2021

Neil DSc

F-star Therapeutics

Chief Scientific Officer

News

You may also like